Tvardi Therapeutics (TVRD) Q2 2026 Earnings

May 8Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.22
-2.34
-1.46
-0.59

Details

Expected EPS
-0.744286
Actual EPS
-0.73
Surprise EPS
0.01
Surprise Percent
+1.92%

Description

⁨Tvardi Therapeutics⁩ (⁦TVRD⁩) has reported earnings of ⁦-0.73⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts